CDK5RAP3 and neoplasm: However, when both genes are simultaneously abrogated, tumor progression is extremely enhanced, and tumor cells acquire resistance to DNA-damaging drugs, a phenotype that resembles our findings related to CDK5RAP3 depletion [51,52,53,54].